Serum osteoprotegerin as an early marker of chronic kidney disease in hypertensive patients
Background Serum osteoprotegerin (OPG) is a marker of cardiovascular disease. The deterioration of renal function in diabetic patients could be predicted by OPG concentrations, and it was suggested that OPG could be used as a risk marker for chronic kidney disease (CKD) in patients with hypertension...
Saved in:
Main Authors: | Khaled A Elhefnawy (Author), Ezzat M Mohamed (Author), Athar M Abou Yousef (Author), Abeer A Fikry (Author), Hala M Allam (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
OSTEOPROTEGERIN AS A PREDICTIVE MARKER OF THE COURSE OF BREAST CANCER
by: S. I. Zabroda, et al.
Published: (2015) -
Value of serum osteoprotegerin in the assessment of endothelial dysfunction in obesity
by: Ahmed Mohammed Shennawy, et al.
Published: (2024) -
Osteoprotegerin Is more than a Possible Serum Marker in Liver Fibrosis: A Study into Its Function in Human and Murine Liver
by: Adhyatmika Adhyatmika, et al.
Published: (2020) -
Gene variants of osteoprotegerin, estrogen-, calcitonin- and vitamin D-receptor genes and serum markers of bone metabolism in patients with Gaucher disease type 1
by: Zimmermann A, et al.
Published: (2018) -
Relationship between subclinical hypothyroidism and serum osteoprotegerin level in type 2 diabetic patients
by: Eman H El-Adawy, et al.
Published: (2017)